Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia

被引：15

作者：

Dancik, Garrett M. ^{[1
]}

Voutsas, Ioannis F. ^{[2
]}

Vlahopoulos, Spiros ^{[3
]}

机构：

[1] Eastern Connecticut State Univ, Dept Comp Sci, Willimantic, CT 06226 USA

[2] St Savas Canc Hosp, Canc Immunol & Immunotherapy Ctr, 171 Alexandras Ave, Athens 11522, Greece

[3] Natl & Kapodistrian Univ Athens, Dept Pediat 1, Thivon & Levadeias 8, Athens 11527, Greece

来源：

MOLECULAR BIOLOGY REPORTS | 2022年 / 49卷 / 04期

关键词：

Aldehyde dehydrogenase; Drug resistance; Immunosuppression; Leukemia; myeloid; acute; Neoplastic Stem cells; Gene expression; Biomarkers; NF-KAPPA-B; ALDEHYDE DEHYDROGENASE 1A1; ACUTE MYELOGENOUS LEUKEMIA; TRANS-RETINOIC ACID; STEM-CELLS; CYTOSINE-ARABINOSIDE; DOWN-REGULATION; AML; FLT3; MECHANISM;

D O I：

10.1007/s11033-021-07073-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The expression and activity of enzymes that belong to the aldehyde dehydrogenases is a characteristic of both normal and malignant stem cells. ALDH1A1 is an enzyme critical in cancer stem cells. In acute myeloid leukemia (AML), ALDH1A1 protects leukemia-initiating cells from a number of antineoplastic agents, which include inhibitors of protein tyrosine kinases. Furthermore, ALDH1A1 proves vital for the establishment of human AML xenografts in mice. We review here important studies characterizing the role of ALDH1A1 in AML and its potential as a therapeutic target. We also analyze datasets from leading studies, and show that decreased ALDH1A1 RNA expression consistently characterizes the AML patient risk group with a favorable prognosis, while there is a consistent association of high ALDH1A1 RNA expression with high risk and poor overall survival. Our review and analysis reinforces the notion to employ both novel as well as existing inhibitors of the ALDH1A1 protein against AML.

引用

页码：3321 / 3331

页数：11

共 97 条

[1] Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species [J].

Allison, Sarah E. ;

Chen, Yongjuan ;

Petrovic, Nenad ;

Zhang, Jian ;

Bourget, Kirsi ;

Mackenzie, Peter I. ;

Murray, Michael .

BIOCHEMICAL PHARMACOLOGY, 2017, 143 :79-89

[2] Autophagy Is a Survival Mechanism of Acute Myelogenous Leukemia Precursors during Dual mTORC2/mTORC1 Targeting [J].

Altman, Jessica K. ;

Szilard, Amy ;

Goussetis, Dennis J. ;

Sassano, Antonella ;

Colamonici, Marco ;

Gounaris, Elias ;

Frankfurt, Olga ;

Giles, Francis J. ;

Eklund, Elizabeth A. ;

Beauchamp, Elspeth M. ;

Platanias, Leonidas C. .

CLINICAL CANCER RESEARCH, 2014, 20 (09) :2400-2409

[3] Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system [J].

Anderson, David W. ;

Schray, Rebecca C. ;

Duester, Gregg ;

Schneider, Jay S. .

BRAIN RESEARCH, 2011, 1408 :81-87

[4] NCBI GEO: archive for functional genomics data sets-update [J].

Barrett, Tanya ;

Wilhite, Stephen E. ;

Ledoux, Pierre ;

Evangelista, Carlos ;

Kim, Irene F. ;

Tomashevsky, Maxim ;

Marshall, Kimberly A. ;

Phillippy, Katherine H. ;

Sherman, Patti M. ;

Holko, Michelle ;

Yefanov, Andrey ;

Lee, Hyeseung ;

Zhang, Naigong ;

Robertson, Cynthia L. ;

Serova, Nadezhda ;

Davis, Sean ;

Soboleva, Alexandra .

NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D991-D995

[5] Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML [J].

Basilico, Silvia ;

Wang, Xiaonan ;

Kennedy, Alison ;

Tzelepis, Konstantinos ;

Giotopoulos, George ;

Kinston, Sarah J. ;

Quiros, Pedro M. ;

Wong, Kim ;

Adams, David J. ;

Carnevalli, Larissa S. ;

Huntly, Brian J. P. ;

Vassiliou, George S. ;

Calero-Nieto, Fernando J. ;

Gottgens, Berthold .

NATURE COMMUNICATIONS, 2020, 11 (01)

[6] Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking [J].

Bidan, Nadege ;

Bailleul-Dubois, Justine ;

Duval, Jeremy ;

Winter, Marie ;

Denoulet, Marie ;

Hannebicque, Karine ;

El-Sayed, Ihsan Y. ;

Ginestier, Christophe ;

Forissier, Violaine ;

Charafe-Jauffret, Emmanuelle ;

Macario, Manon ;

Matsunaga, Yukiko T. ;

Meignan, Samuel ;

Anquez, Francois ;

Julien, Sylvain ;

Bonnefond, Amelie ;

Derhourhi, Mehdi ;

Le Bourhis, Xuefen ;

Lagadec, Chann .

PROTEOMICS, 2019, 19 (21-22)

[7] Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway [J].

Birkenkamp, KU ;

Geugien, M ;

Schepers, H ;

Westra, J ;

Lemmink, HH ;

Vellenga, E .

LEUKEMIA, 2004, 18 (01) :103-112

[8] Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells [J].

Bogen, Anja ;

Buske, Christian ;

Hiddemann, Wolfgang ;

Bohlander, Stefan K. ;

Christ, Oliver .

EXPERIMENTAL HEMATOLOGY, 2017, 47 :54-63

[9] Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites [J].

Bosc, Claudie ;

Broin, Nicolas ;

Fanjul, Marjorie ;

Saland, Estelle ;

Farge, Thomas ;

Courdy, Charly ;

Batut, Aurelie ;

Masoud, Rawand ;

Larrue, Clement ;

Skuli, Sarah ;

Espagnolle, Nicolas ;

Pages, Jean-Christophe ;

Carrier, Alice ;

Bost, Frederic ;

Bertrand-Michel, Justine ;

Tamburini, Jerome ;

Recher, Christian ;

Bertoli, Sarah ;

Mansat-De Mas, Veronique ;

Manenti, Stephane ;

Sarry, Jean-Emmanuel ;

Joffre, Carine .

NATURE COMMUNICATIONS, 2020, 11 (01)

[10] Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression [J].

Bradbury, DA ;

Aldington, S ;

Zhu, YM ;

Russell, NH .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (04) :671-675

← 1 2 3 4 5 6 7 8 9 10 →